Procyon Advisors, LLC Ocugen, Inc. Transaction History
Procyon Advisors, LLC
- $6.19 Billion
- Q4 2025
A detailed history of Procyon Advisors, LLC transactions in Ocugen, Inc. stock. As of the latest transaction made, Procyon Advisors, LLC holds 224,100 shares of OCGN stock, worth $266,679. This represents 0.0% of its overall portfolio holdings.
Number of Shares
224,100
Previous 211,100
6.16%
Holding current value
$266,679
Previous $344,000
22.67%
% of portfolio
0.0%
Previous 0.01%
Shares
3 transactions
Others Institutions Holding OCGN
# of Institutions
107Shares Held
61.4MCall Options Held
531KPut Options Held
433K-
Black Rock Inc. New York, NY17.9MShares$21.3 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA15.2MShares$18.1 Million0.0% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny4.16MShares$4.95 Million0.0% of portfolio
-
Gmt Capital Corp Atlanta, GA4.15MShares$4.94 Million0.31% of portfolio
-
Geode Capital Management, LLC Boston, MA3.68MShares$4.38 Million0.0% of portfolio
About Ocugen, Inc.
- Ticker OCGN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 216,566,000
- Market Cap $258M
- Description
- Ocugen, Inc., a clinical-stage biopharmaceutical company, focuses on the developing gene therapies to cure blindness diseases. The company's pipeline product includes OCU400, a novel gene therapy product candidate restoring retinal integrity and function across a range of genetically diverse inherited retinal diseases, such as retinitis pigmento...